News updates

COVID-19 vaccination during pregnancy and neonatal health

Using data from the Dutch Pregnancy Drug Register, Netherlands Pharmacovigilance Centre Lareb found no association between COVID-19 v...

Nerve damage due to the use of nutritional supplements with vitamin B6

The Netherlands Pharmacovigilance Centre Lareb has previously reported on nerve damage caused by the use of nutritional ...

MedSafetyWeek 2024

Today, the MedSafetyWeek starts. The MedSafetyWeek is an annual (social) media campaign focussing on raising awareness of pharmacovigilance, and promoting recognition and r...

Fever and mebendazole

Until July 2024, the Netherlands Pharmacovigilance Centre Lareb received 23 reports of fever following use of mebendazole. Fever is not a known side effect of mebendazol...

Highlighting challenges in monitoring herbal products and presenting universal recommendations

Lareb conducted a study comprised of semi-structured interviews in order to explore the current ...

Prolonged duration of COVID-19 vaccine-induced lymphadenopathy

The Netherlands Pharmacovigilance Centre Lareb has received reports of enlarged lymph nodes after COVID-19 vaccination that do n...

Possible ischaemic colitis after bisacodyl use

The Netherlands Pharmacovigilance Centre Lareb received two reports of ischaemic colitis after bisacodyl use. Ischaemic colitis often resolves s...

Anaphylactic reaction to the complex of rocuronium and sugammadex

The sugammadex-rocuronium complex can cause severe allergic reactions. Also in patients who are not allergic to one of the in...

Agnes Kant appointed as professor at Leiden University

Epidemiologist and director of the Netherlands Pharmacovigilance Centre Lareb, Agnes Kant, has been appointed as professor in pharmacovi...